Posted innews Respiratory
Immunomodulatory Effects of Clarithromycin in Community-Acquired Pneumonia: Insights from the ACCESS Trial’s Inflammatory Proteome Analysis
This study reveals that clarithromycin modulates inflammatory cytokines in community-acquired pneumonia, identifying distinct immune endotypes that may guide personalized immunomodulatory therapy.